Skip to content

Novel Adverse Effect of Tranexamic Acid in Adolescent Idiopathic Scoliosis Surgery

A Novel Adverse Effect of Tranexamic Acid in Adolescent Idiopathic Scoliosis Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201805003406118
Enrollment
75
Registered
2018-05-22
Start date
2018-03-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Interventions

Control Group
Group HD (High Dose)
Group LD (Low Dose)

Sponsors

Ain Shams University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This randomized controlled clinical trial will be conducted on 75 patients with American Society of Anesthesiologists (ASA) physical status I and II, of either sex, 12-18 years of age, who will be scheduled for elective single stage posterior spine fusion surgery for idiopathic scoliosis under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients known to have renal or hepatic disorder, bleeding diathesis, thromboembolic event 1 year prior to surgery, preoperative anemia (hemoglobin 1.4 and history of uncontrolled hypertension will be dismissed from the study. Additionally, patients with neuromuscular disease, congenital or syndromic scoliosis or surgery performed via either combined anterior and posterior spinal fusions or the anterior procedure are excluded. Severe pulmonary disease, i.e., FEV1 < 50% normal will be also excluded from the study

Design outcomes

Primary

MeasureTime frame
Total dose given of intraoperative fentanyl

Secondary

MeasureTime frame
Intraoperative blood loss, time of surgery and perioperative complications

Countries

Egypt

Contacts

Public ContactAshraf Nabil Saleh

Lecturer of Anesthesia Ain Shams University

ashraf_nabil95@yahoo.com002 010001100613

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026